Show simple item record

dc.contributor.authorBoos, Karl-Siegfried
dc.contributor.authorCaglar, Sena
dc.contributor.authorMorello, Rosa
dc.date.accessioned2021-03-03T16:35:47Z
dc.date.available2021-03-03T16:35:47Z
dc.identifier.citationCaglar S., Morello R., Boos K., "Development and validation of an on-line multidimensional SPE-LC-MS/MS method for the quantitation of Tetrandrine in blood samples", JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, cilt.988, ss.25-32, 2015
dc.identifier.issn1570-0232
dc.identifier.othervv_1032021
dc.identifier.otherav_451887ab-9c70-41ff-aec8-f3563aef1f4c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/50116
dc.identifier.urihttps://doi.org/10.1016/j.jchromb.2015.02.021
dc.description.abstractOn-line solid-phase extraction (SPE) is becoming an increasingly widespread technique in the clean-up of complex matrices such as body fluids, prior to chromatographic analysis. The use of small SPE columns instead of disposable SPE cartridges allows multiple injections and complete automation. In addition, it decreases the cost of consumables and improves the quality of the overall analysis. Coupling of SPE with HPLC combines sample preparation and separation in one system. In this paper a validated online multidimensional (MD) SPE-LC-MS/MS method is described for the determination of Tetrandrine (model drug) in human blood samples. The developed method showed the applicability of direct injection of plasma samples to an on-line MD-SPE-LC-MS/MS system to determine small molecules i.e. drugs. The experimental design is unique. Quantification was through tandem mass spectrometry with positive electrospray ionization (ESI) and multiple reactions monitoring (MRM). The limit of detection was calculated as 31.98 ng/mL. The linear range of the method was between 40.0 and 800.0 ng/mL. Pharmacokinetic parameters are usually determined by analysis of drug concentrations in plasma rather than whole blood. Parameters determined using plasma data may be misleading if concentrations of drug differ between plasma and red blood cells. We successfully applied the developed method for the determination of the distribution coefficient of the model drug Tetrandrine between human red blood cells and blood plasma proteins. The determination of distribution coefficient study results demonstrated that the developed method can provide direct and accurate measurement of RBC partitioning in a model drug and could be applied for screening of other compounds for potential high RBC partition, predicting potential drug toxicity and investigating mechanisms associated with RBC partitions. (C) 2015 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectAnalitik Kimya
dc.subjectTemel Bilimler
dc.subjectTemel Bilimler (SCI)
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectKimya
dc.subjectKİMYA, ANALİTİK
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBiyoloji ve Biyokimya
dc.subjectBİYOKİMYASAL ARAŞTIRMA YÖNTEMLERİ
dc.titleDevelopment and validation of an on-line multidimensional SPE-LC-MS/MS method for the quantitation of Tetrandrine in blood samples
dc.typeMakale
dc.relation.journalJOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
dc.contributor.departmentUniversity of Munich , ,
dc.identifier.volume988
dc.identifier.startpage25
dc.identifier.endpage32
dc.contributor.firstauthorID221585


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record